logo

For the Inventor, By the Inventor

Philadelphia, PA, United States of America

Oncoceutics, Inc.

Calculating rank
USPTO Granted Patents = 14


Forward Citations = 31

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Joshua E Allen (14 out of 24 patents)

silverMedal Martin Stogniew (14 out of 49 patents)

bronzeMedal Varun Vijay Prabhu (5 out of 5 patents)

4.  Richard S Pottorf (5 out of 6 patents)

5.  Bhaskara Rao Nallaganchu (5 out of 10 patents)

6.  Gary Olson (5 out of 31 patents)

7.  Yanjun Sun (3 out of 6 patents)

8.  Gary L Olson (0 patent)

9.  Gary L Olson (0 patent)


14 patents:

1. 12102639 - Imipridones for gliomas (2024-10-01),
2. 11976068 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2024-05-07),
3. 11116771 - G protein-coupled receptor (GPCR) modulation by imipridones (2021-09-14),
4. 10953014 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2021-03-23),
5. 10946022 - Imipridones for gliomas (2021-03-16),
6. 10456402 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2019-10-29),
7. 10369154 - Imipridones for gliomas (2019-08-06),
8. 10266533 - 7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2019-04-23),
9. 10172862 - Imipridones for gliomas (2019-01-08),
10. 10045992 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy (2018-08-14),
11. 9845324 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2017-12-19),
12. 9688679 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2017-06-27),
13. 9376437 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy (2016-06-28),
14. 9265765 - 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy (2016-02-23),
Company Overview
Oncoceutics, Inc. is a biopharmaceutical company based in Philadelphia, PA, focused on developing innovative therapies for cancer treatment. The organization specializes in the research and development of novel compounds aimed at targeting specific cancer pathways, with an emphasis on improving patient outcomes. By leveraging advanced scientific insights and technologies, Oncoceutics seeks to address unmet medical needs in oncology, contributing to the evolving landscape of cancer care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#72 in Philadelphia, PA

#803 in Pennsylvania

#22,344 in US

#42,312 in the World

Philadelphia, PA (US)
Philadelphia, PA, United States of America

Oncoceutics, Inc.

Forward Citations = 31

8 inventors:

goldMedal Joshua E Allen (14 out of 24 patents)

silverMedal Martin Stogniew (14 out of 49 patents)

bronzeMedal Varun Vijay Prabhu (5 out of 5 patents)

4.  Richard S Pottorf (5 out of 6 patents)

5.  Bhaskara Rao Nallaganchu (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oncoceutics, Inc.. Retrieved from https://idiyas.com/company/oncoceutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…